<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03487484</url>
  </required_header>
  <id_info>
    <org_study_id>QoL Rectal Cancer</org_study_id>
    <nct_id>NCT03487484</nct_id>
  </id_info>
  <brief_title>Quality of Life in Patients With Rectal Cancer Receiving Total Mesorectal Excision With or Without Stoma</brief_title>
  <official_title>Quality of Life in Patients With Rectal Cancer Receiving Neoadjuvant Chemotherapy, Total Mesorectal Excision With or Without Stoma and Adjuvant Chemotherapy: a Prospective, Single-centre Pilot-study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Basel, Switzerland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Basel, Switzerland</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal is to evaluate whether the renunciation of a diverting stoma in patients with
      adjuvant chemotherapy after low anterior resection with total mesorectal excision (TME) and
      neoadjuvant chemoradiotherapy leads to a better quality of life without increasing morbidity
      and mortality in patients with rectal cancer.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In most cases it is recommended that patients after low anterior resection with TME and
      neoadjuvant chemoradiotherapy for rectal cancer need a temporarily diverting stoma. Recent
      evidence suggests that this is not always necessary. The decision for or against a stoma is
      made by the surgeon in charge and is based on an algorithm of risk factors for anastomotic
      leakage. Many patients receive an adjuvant chemotherapy postoperative. This may influence the
      quality of life e.a. due to mucositis and urge incontinency or the stoma itself.The objective
      of this pilot study is to establish the basis for a randomized controlled trial. The
      long-term goal is to evaluate whether the renunciation of a diverting stoma in patients with
      adjuvant chemotherapy after low anterior resection with TME and neoadjuvant chemoradiotherapy
      leads to a better quality of life without increasing morbidity and mortality in patients with
      rectal cancer. All patients scheduled for low anterior resection of the rectum for rectal
      carcinoma will be invited to participate and prospectively enrolled into the study.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 22, 2018</start_date>
  <completion_date type="Anticipated">March 22, 2020</completion_date>
  <primary_completion_date type="Anticipated">March 22, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change in quality of life specific for the gastrointestinal tract</measure>
    <time_frame>at Baseline and up to 12 months after surgery</time_frame>
    <description>GIQLI Score</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in quality of life</measure>
    <time_frame>at Baseline and up to 12 months after surgery</time_frame>
    <description>Short Form (SF) 36</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in faecal Incontinence</measure>
    <time_frame>at Baseline and up to 12 months after surgery</time_frame>
    <description>Vaizey Wexner Score</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Rectal Cancer</condition>
  <arm_group>
    <arm_group_label>With protective stoma</arm_group_label>
    <description>Patients in which intraoperatively the decision was made to add a protective stoma (following a risk algorithm) to total mesorectal excision. In patients quality of life, the Gastrointestinal Quality of Life Index (GIQLI) questionnaire, Quality of Life Questionnaire for gastrointestinal tract and Faecal Incontinence Score will be applied.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No stoma</arm_group_label>
    <description>Patients in which intraoperatively the decision was made to refrain from adding a protective stoma (following a risk algorithm) to total mesorectal excision.
In patients quality of life, the GIQLI questionnaire (Gastrointestinal Quality of Life Index), Quality of Life Questionnaire for gastrointestinal tract and Faecal Incontinence Score will be applied.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Quality of Life Questionnaire for gastrointestinal tract</intervention_name>
    <description>To assess quality of life, the GIQLI questionnaire (Gastrointestinal Quality of Life Index) will be applied</description>
    <arm_group_label>With protective stoma</arm_group_label>
    <arm_group_label>No stoma</arm_group_label>
    <other_name>GIQLI questionnaire</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Quality of Life Questionnaire</intervention_name>
    <description>To assess quality of life, the SF-36 questionnaire will be applied</description>
    <arm_group_label>With protective stoma</arm_group_label>
    <arm_group_label>No stoma</arm_group_label>
    <other_name>SF-36 questionnaire</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Faecal Incontinence Score</intervention_name>
    <description>To assess faecal incontinence, the Vaizey Wexner questionnaire will be applied</description>
    <arm_group_label>With protective stoma</arm_group_label>
    <arm_group_label>No stoma</arm_group_label>
    <other_name>Vaizey Wexner questionnaire</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with newly diagnosed rectal cancer
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age older than 18,

          -  low anterior resection and TME due to rectum carcinoma after standardized neoadjuvant
             combined chemo- and radiotherapy and receiving adjuvant postoperative chemotherapy,

          -  German speaking patient who is capable to fill in the questionnaire,

          -  signed informed consent

        Exclusion Criteria:

          -  age younger than 18,

          -  preoperative stoma,

          -  not German speaking

          -  inability to fill in the questionnaire,

          -  no standardized chemo- and radiotherapy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Susanne Drews, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Claraspital Basel</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Bettina Wölnerhanssen, MD</last_name>
    <phone>0041616858585</phone>
    <email>bettina.woelnerhanssen@usb.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Bettina Wölnerhanssen</last_name>
    <phone>0041616858585</phone>
    <email>bettina.woelnerhanssen@usb.ch</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>St Claraspital</name>
      <address>
        <city>Basel</city>
        <zip>4058</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bettina Wölnerhanssen, MD</last_name>
      <phone>0041616858585</phone>
    </contact>
    <investigator>
      <last_name>Susanne Drews, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 26, 2018</study_first_submitted>
  <study_first_submitted_qc>April 3, 2018</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 4, 2018</study_first_posted>
  <last_update_submitted>April 3, 2018</last_update_submitted>
  <last_update_submitted_qc>April 3, 2018</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 4, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rectal Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

